Anavex Life Sciences Corp. Company Profile (NASDAQ:AVXL)

About Anavex Life Sciences Corp. (NASDAQ:AVXL)

Anavex Life Sciences Corp. logoAnavex Life Sciences Corp., is a clinical-stage biopharmaceutical company engaged in the development of drug candidates. The Company's lead compounds include ANAVEX 2-73, ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), ANAVEX 19-144, ANAVEX 1-41, ANAVEX 7-1037, ANAVEX 3-71, ANAVEX 1079, ANAVEX 1519 and ANAVEX 1066 being developed to treat Alzheimer's disease and other central nervous system (CNS) diseases. The Company's SIGMACEPTOR Discovery Platform produced small molecule drug candidates with unique modes of action. Sigma receptors may be targets for therapeutics to combat many human diseases, including Alzheimer's disease. When bound by the appropriate ligands, sigma receptors influence the functioning of multiple biochemical signals that are involved in the pathogenesis (origin or development) of disease.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Symbol: NASDAQ:AVXL
  • CUSIP: N/A
  • Web: www.anavex.com
Capitalization:
  • Market Cap: $240.39 million
  • Outstanding Shares: 41,376,000
Average Prices:
  • 50 Day Moving Avg: $5.84
  • 200 Day Moving Avg: $4.96
  • 52 Week Range: $2.43 - $8.30
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -8.42
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: N/A
  • Price / Sales: N/A
  • Book Value: $0.52 per share
  • Price / Book: 11.17
Profitability:
  • EBIDTA: ($14,200,000.00)
  • Return on Equity: -131.78%
  • Return on Assets: -106.85%
Debt:
  • Current Ratio: 9.74%
  • Quick Ratio: 9.74%
Misc:
  • Average Volume: 402,729 shs.
  • Beta: -0.27
  • Short Ratio: 8.16
 

Frequently Asked Questions for Anavex Life Sciences Corp. (NASDAQ:AVXL)

What is Anavex Life Sciences Corp.'s stock symbol?

Anavex Life Sciences Corp. trades on the NASDAQ under the ticker symbol "AVXL."

How were Anavex Life Sciences Corp.'s earnings last quarter?

Anavex Life Sciences Corp. (NASDAQ:AVXL) posted its quarterly earnings data on Tuesday, February, 7th. The company reported ($0.08) EPS for the quarter. View Anavex Life Sciences Corp.'s Earnings History.

Where is Anavex Life Sciences Corp.'s stock going? Where will Anavex Life Sciences Corp.'s stock price be in 2017?

3 brokerages have issued 1-year price targets for Anavex Life Sciences Corp.'s shares. Their predictions range from $10.00 to $16.00. On average, they anticipate Anavex Life Sciences Corp.'s share price to reach $13.67 in the next year. View Analyst Ratings for Anavex Life Sciences Corp..

Who are some of Anavex Life Sciences Corp.'s key competitors?

Who owns Anavex Life Sciences Corp. stock?

Anavex Life Sciences Corp.'s stock is owned by a variety of of retail and institutional investors. Top institutional investors include Park West Asset Management LLC (7.20%), Vanguard Group Inc. (0.00%), Geode Capital Management LLC (0.00%), TIAA CREF Investment Management LLC (0.00%), Bank of New York Mellon Corp (0.27%) and Teachers Advisors LLC (0.00%). View Institutional Ownership Trends for Anavex Life Sciences Corp..

Who sold Anavex Life Sciences Corp. stock? Who is selling Anavex Life Sciences Corp. stock?

Anavex Life Sciences Corp.'s stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, TIAA CREF Investment Management LLC, Highbridge Capital Management LLC, Credit Suisse AG, Russell Investments Group Ltd. and Nationwide Fund Advisors. View Insider Buying and Selling for Anavex Life Sciences Corp..

Who bought Anavex Life Sciences Corp. stock? Who is buying Anavex Life Sciences Corp. stock?

Anavex Life Sciences Corp.'s stock was acquired by a variety of institutional investors in the last quarter, including Park West Asset Management LLC, Vanguard Group Inc., Edge Wealth Management LLC, Geode Capital Management LLC, JPMorgan Chase & Co., Teachers Advisors LLC, Bank of New York Mellon Corp and Bank of America Corp DE. View Insider Buying and Selling for Anavex Life Sciences Corp..

How do I buy Anavex Life Sciences Corp. stock?

Shares of Anavex Life Sciences Corp. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Anavex Life Sciences Corp. stock cost?

One share of Anavex Life Sciences Corp. stock can currently be purchased for approximately $5.81.

Analyst Ratings

Consensus Ratings for Anavex Life Sciences Corp. (NASDAQ:AVXL) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $13.67 (135.23% upside)

Analysts' Ratings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/22/2017Maxim GroupSet Price TargetBuy$15.00LowView Rating Details
5/14/2017Noble FinancialReiterated RatingBuyLowView Rating Details
10/5/2016FBR & CoReiterated RatingOutperform$10.00N/AView Rating Details
(Data available from 5/24/2015 forward)

Earnings

Earnings History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Earnings by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Earnings History by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/7/2017Q1 2017($0.08)ViewN/AView Earnings Details
8/11/2016Q316($0.09)($0.06)ViewN/AView Earnings Details
5/11/2016Q2($0.16)($0.06)ViewN/AView Earnings Details
2/8/2016Q116($0.12)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Current Year EPS Consensus Estimate: $-0.53 EPS
Next Year EPS Consensus Estimate: $-0.69 EPS

Dividends

Dividend History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Insider Ownership Percentage: 9.37%
Institutional Ownership Percentage: 11.59%
Insider Trades by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Institutional Ownership by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Insider Trades by Quarter for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/14/2015Christopher U MisslingCEOBuy1,000$0.52$520.00View SEC Filing  
7/13/2015Christopher U MisslingCEOBuy1,000$0.53$530.00View SEC Filing  
7/7/2015Christopher U MisslingCEOBuy2,000$0.49$980.00View SEC Filing  
7/1/2015Christopher U MisslingCEOBuy2,000$0.45$900.00View SEC Filing  
6/23/2015Christopher U MisslingCEOBuy1,000$0.47$470.00View SEC Filing  
6/22/2015Christopher U MisslingCEOBuy1,000$0.42$420.00View SEC Filing  
6/16/2015Christopher U MisslingCEOBuy1,000$0.44$440.00View SEC Filing  
6/15/2015Christopher U MisslingCEOBuy1,000$0.43$430.00View SEC Filing  
6/10/2015Christopher U MisslingCEOBuy1,000$0.36$360.00View SEC Filing  
6/8/2015Christopher U MisslingCEOBuy1,000$0.35$350.00View SEC Filing  
6/4/2015Christopher U MisslingCEOBuy1,000$0.37$370.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Latest Headlines for Anavex Life Sciences Corp. (NASDAQ:AVXL)
Source:
DateHeadline
americanbankingnews.com logoMaxim Group Reiterates $15.00 Price Target for Anavex Life Sciences Corp. (AVXL)
www.americanbankingnews.com - May 23 at 7:28 PM
streetinsider.com logoAnavex Life Sciences (AVXL) Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders - StreetInsider.com
www.streetinsider.com - May 22 at 3:43 PM
finance.yahoo.com logoAnavex Life Sciences Reports New Data for ANAVEX 2-73 in Neurodevelopmental Disorders Including Angelman Syndrome: Data Presented at Antiepileptic Drug Trials XIV 2017 Conference
finance.yahoo.com - May 22 at 9:51 AM
seekingalpha.com logoAnavex Life Sciences: 5 Reasons Why I'm Short
seekingalpha.com - May 19 at 3:41 PM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Earns Buy Rating from Noble Financial
www.americanbankingnews.com - May 14 at 8:45 AM
finance.yahoo.com logoAnavex Reports Fiscal Second Quarter 2017 Financial Results
finance.yahoo.com - May 11 at 1:59 AM
globenewswire.com logoAnavex Reports Fiscal Second Quarter 2017 Financial Results - GlobeNewswire (press release)
globenewswire.com - May 10 at 9:01 AM
marketbeat.com logoAnavex Life Sciences reports 2Q loss
marketbeat.com - May 10 at 7:28 AM
americanbankingnews.com logoZacks: Analysts Anticipate Anavex Life Sciences Corp. (AVXL) Will Announce Earnings of -$0.09 Per Share
www.americanbankingnews.com - May 8 at 10:48 AM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) to Release Quarterly Earnings on Tuesday
www.americanbankingnews.com - May 7 at 7:08 AM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Earning Somewhat Positive Media Coverage, Report Shows
www.americanbankingnews.com - May 3 at 11:20 PM
finance.yahoo.com logoAnavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs - Yahoo Finance
finance.yahoo.com - May 3 at 3:50 PM
globenewswire.com logoAnavex Life Sciences Appoints Former FDA Officer as Senior Vice ... - GlobeNewswire (press release)
globenewswire.com - May 1 at 9:22 AM
finance.yahoo.com logoAnavex Life Sciences Appoints Former FDA Officer as Senior Vice President of Regulatory Affairs
finance.yahoo.com - May 1 at 9:22 AM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Earns Media Impact Rating of 0.57
www.americanbankingnews.com - April 29 at 9:38 AM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Earning Somewhat Favorable Press Coverage, Study Finds
www.americanbankingnews.com - April 26 at 4:56 PM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Receiving Somewhat Favorable Press Coverage, Study Shows
www.americanbankingnews.com - April 22 at 1:36 PM
americanbankingnews.com logoZacks: Analysts Expect Anavex Life Sciences Corp. (AVXL) Will Post Earnings of -$0.09 Per Share
www.americanbankingnews.com - April 17 at 11:52 AM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Earns News Impact Rating of 0.57
www.americanbankingnews.com - April 14 at 8:24 AM
finance.yahoo.com logoCan Anavex (AVXL) Run Higher on Strong Earnings Estimate Revisions?
finance.yahoo.com - April 13 at 3:54 PM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Raised to "Buy" at Zacks Investment Research
www.americanbankingnews.com - April 12 at 4:37 PM
finance.yahoo.com logoFor These Small-Cap Biotech CEOs, Stock Promotion, not Drug Development, was Priority No. 1
finance.yahoo.com - April 11 at 3:46 PM
americanbankingnews.com logoAnavex Life Sciences Corp. (AVXL) Stock Rating Reaffirmed by Noble Financial
www.americanbankingnews.com - April 9 at 7:10 AM
americanbankingnews.com logo Anavex Life Sciences Corp. (AVXL) Given Average Rating of "Strong Buy" by Analysts
www.americanbankingnews.com - April 4 at 12:43 AM
us.rd.yahoo.com logo7:10 am Anavex announces the presentation of new mechanism of action data related to ANAVEX compounds targeting the sigma-1 receptor at the AD/PDTM 2017 Meeting
us.rd.yahoo.com - April 3 at 4:09 PM
globenewswire.com logoAnavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit - GlobeNewswire (press release)
globenewswire.com - March 31 at 8:51 PM
finance.yahoo.com logo8:04 am Anavex announces that the dismissal of the appeal in the Cortina v. Anavex Life Sciences Corp lawsuit, without payment of any fees or costs by the Co
finance.yahoo.com - March 30 at 4:09 PM
feeds.benzinga.com logoAnavex Life Sciences Reports Dismissal of Appeal in the Cortina Lawsuit
feeds.benzinga.com - March 30 at 9:10 AM
streetinsider.com logoAnavex Life Sciences (AVXL) to Present at AD/PD Conference - StreetInsider.com
www.streetinsider.com - March 29 at 12:48 PM
finance.yahoo.com logoAnavex Life Sciences to Present at the 13th International Conference on Alzheimer's and Parkinson's Diseases AD/PD™ 2017
finance.yahoo.com - March 29 at 12:48 PM
thestreet.com logoBiotech Stock Mailbag: Sage Therapeutics, Cellceutix, Alzheimer's Risk
www.thestreet.com - March 24 at 4:08 PM
seekingalpha.com logoAnavex Life Sciences (AVXL) Presents At Oppenheimer 27th Annual Healthcare Conference - Slideshow
seekingalpha.com - March 23 at 4:10 PM
feeds.benzinga.com logoAlzheimer's Pipeline In Focus At Oppenheimer Conference As Neurotrope's Trial Results Approach
feeds.benzinga.com - March 22 at 2:49 PM
finance.yahoo.com logoAnavex Life Sciences to Present at Oppenheimer 27th Annual Healthcare Conference
finance.yahoo.com - March 15 at 3:57 PM
globenewswire.com logoAnavex Life Sciences to Present at 14th Annual BIO Asia International Conference - GlobeNewswire (press release)
globenewswire.com - March 13 at 3:55 PM
finance.yahoo.com logoAnavex Life Sciences to Present at 14th Annual BIO Asia International Conference
finance.yahoo.com - March 13 at 9:31 AM
thestreet.com logoInteresting AVXL Put And Call Options For October 20th - TheStreet.com
www.thestreet.com - February 22 at 3:46 PM
streetinsider.com logoAnavex Life Sciences (AVXL) Appoints Peter Donhauser to Board of Directors
www.streetinsider.com - February 13 at 4:16 PM
finance.yahoo.com logoAnavex Life Sciences Strengthens Board of Directors
finance.yahoo.com - February 13 at 4:16 PM
globenewswire.com logoAnavex Life Sciences' CEO Joins BIO CEO & Investor Conference 2017 Panel “Designing Clinical Trials in 21st ... - GlobeNewswire (press release)
globenewswire.com - February 9 at 3:54 PM
finance.yahoo.com logoAnavex Life Sciences’ CEO Joins BIO CEO & Investor Conference 2017 Panel “Designing Clinical Trials in 21st Century Cures Paradigm”
finance.yahoo.com - February 9 at 3:54 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today - Motley Fool
www.fool.com - February 8 at 3:38 PM
biz.yahoo.com logoANAVEX LIFE SCIENCES CORP. Files SEC form 10-Q, Quarterly Report
biz.yahoo.com - February 8 at 3:38 PM
us.rd.yahoo.com logoAnavex Reports Fiscal First Quarter 2017 Financial Results
us.rd.yahoo.com - February 7 at 4:41 PM
finance.yahoo.com logoNoble Capital Markets Initiates Research Coverage on Anavex Life Sciences Corp. (AVXL)
finance.yahoo.com - February 7 at 4:41 PM
finance.yahoo.com logoCoverage initiated on Anavex by Noble Financial
finance.yahoo.com - February 7 at 4:41 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today
www.fool.com - February 7 at 4:41 PM
fool.com logoHere's Why Anavex Life Sciences Corp. Surged Today
www.fool.com - February 7 at 2:13 PM
fool.com logoForget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys - Motley Fool
www.fool.com - February 1 at 3:55 PM
fool.com logoForget Anavex Life Sciences Corp.: These 2 Biotech Stocks Are Better Buys
www.fool.com - February 1 at 11:40 AM

Social

Chart

Anavex Life Sciences Corp. (AVXL) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by MarketBeat.com Staff